Evidence map›Paper›PMID 37377616›Full record

ArticleCancer research communications2023

Deconstructing Olfactory Epithelium Developmental Pathways in Olfactory Neuroblastoma.

John B Finlay, Ralph Abi Hachem, David W Jang, Nosayaba Osazuwa-Peters, Bradley J Goldstein

Open access · goldAbstract read
In one paragraph

Article in Cancer research communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

John B FinlayMedical Scientist Training Program, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-3038-1276
Ralph Abi HachemDepartment of Head and Neck Surgery & Communication Sciences, Duke University, School of Medicine, Durham, North Carolina.ORCID 0009-0000-4007-8505
David W JangDepartment of Head and Neck Surgery & Communication Sciences, Duke University, School of Medicine, Durham, North Carolina.ORCID 0000-0003-4200-7174
Nosayaba Osazuwa-PetersDepartment of Head and Neck Surgery & Communication Sciences, Duke University, School of Medicine, Durham, North Carolina.ORCID 0000-0002-1390-9753
Bradley J GoldsteinDepartment of Head and Neck Surgery & Communication Sciences, Duke University, School of Medicine, Durham, North Carolina.ORCID 0000-0002-9612-1696
Duke University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
Therapeutic potential for modulation of olfactory basal stem cellsR01DC016859 · NIDCD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GOLDSTEIN, BRADLEY J · 2018 to 2022
$2.2M
Single cell analysis of human olfactory mucosaR21DC018371 · NIDCD · DUKE UNIVERSITY · PI GOLDSTEIN, BRADLEY J · 2020 to 2021
$443k
Leveraging multi-omics to define the role of epigenetic regulation by PRC2 in EsthesioneuroblastomaF30DC021348 · NIDCD · DUKE UNIVERSITY · PI FINLAY, JOHN BARRATT · 2023 to 2024
$88k
NIDCD NIH HHS F30 DC021348NIDCD NIH HHS R01 DC016859NIDCD NIH HHS R21 DC018371NIGMS NIH HHS T32 GM007171NIGMS NIH HHS T32 GM145449
6 · The paper itself

Abstract

Olfactory neuroblastoma is a rare tumor arising from the olfactory cleft region of the nasal cavity. Because of the low incidence of this tumor, as well as an absence of established cell lines and murine models, understanding the mechanisms driving olfactory neuroblastoma pathobiology has been challenging. Here, we sought to apply advances from research on the human olfactory epithelial neurogenic niche, along with new biocomputational approaches, to better understand the cellular and molecular factors in low- and high-grade olfactory neuroblastoma and how specific transcriptomic markers may predict prognosis. We analyzed a total of 19 olfactory neuroblastoma samples with available bulk RNA-sequencing and survival data, along with 10 samples from normal olfactory epithelium. A bulk RNA-sequencing deconvolution model identified a significant increase in globose basal cell (GBC) and CD8 T-cell identities in high-grade tumors (GBC from ∼0% to 8%, CD8 T cell from 0.7% to 2.2%), and significant decreases in mature neuronal, Bowman's gland, and olfactory ensheathing programs, in high-grade tumors (mature neuronal from 3.7% to ∼0%, Bowman's gland from 18.6% to 10.5%, olfactory ensheathing from 3.4% to 1.1%). Trajectory analysis identified potential regulatory pathways in proliferative olfactory neuroblastoma cells, including PRC2, which was validated by immunofluorescence staining. Survival analysis guided by gene expression in bulk RNA-sequencing data identified favorable prognostic markers such as SOX9, S100B, and PLP1 expression. Significance: Our analyses provide a basis for additional research on olfactory neuroblastoma management, as well as identification of potential new prognostic markers.

Indexed as

Esthesioneuroblastoma, OlfactoryNose NeoplasmsAnimalsHumansMiceOlfactory MucosaOlfactory PathwaysRNARNA

Identifiers

PMID37377616
PMCPMC10243222
OpenAlexW4377108027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.